MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

Clinical trial NCT02660580 · COMPLETED

Trial details

NCT number: NCT02660580
Sponsor: Fresenius Kabi SwissBioSim GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriasis Plaque Type Psoriasis Moderate to Severe Plaque Psoriasis

Start date: 2016-02-16
Primary completion: 2016-12-31
Enrollment: 443

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.